Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvular heart disease (a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Deep Vein Thrombosis
• Peripheral Arterial Disease
• Pulmonary Embolism
• Valvular Heart Disease

Snippet

Sponsor: McMaster University | Conditions: Atrial Fibrillation, Valvular Heart Disease | Phase 3 | Status: WITHDRAWN